1. Nonmetastatic castration-resistant prostate cancer: considerations for metastasis-free survival endpoint in clinical trials Publication: Silver Spring, MD : Center for Drug Evaluation and Research, August 2021 Subject(s): Clinical Trials as TopicProstatic Neoplasms, Castration-ResistantUnited StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration
